✦ LIBER ✦

Antibody Engineering Volume c || Chimeric Antigen Receptors for T-Cell Based Therapy

✍ Scribed by Chames, Patrick

Book ID: 115444735
Publisher: Humana Press
Year: 2012
Weight: 263 KB
Category: Article
ISBN: 1617799742
DOI: 10.1007/978-1-61779-974-7_36

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Auto T cells expressing chimeric antigen

Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma

✍ Pan Weibo; Ye Zhaoming 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A foundation for universal T-cell based

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

✍ Torikai, Hiroki (author);Reik, Andreas (author);Liu, Pei Qi (author);Zhou, Yuany 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 626 KB

A foundation for universal T-cell based

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

✍ Torikai, Hiroki (author);Reik, Andreas (author);Liu, Pei Qi (author);Zhou, Yuany 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 626 KB

A foundation for universal T-cell based

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

✍ Torikai, Hiroki (author);Reik, Andreas (author);Liu, Pei Qi (author);Zhou, Yuany 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 626 KB

Stable, soluble, high-affinity, engineer

Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens

✍ J. M. Boulter; B. K. Jakobsen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies